Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors

Crebbp 的早期缺失赋予淋巴祖细胞恶性干细胞特性

阅读:1
作者:Sarah J Horton ,George Giotopoulos ,Haiyang Yun ,Shabana Vohra ,Olivia Sheppard ,Rachael Bashford-Rogers ,Mamunur Rashid ,Alexandra Clipson ,Wai-In Chan ,Daniel Sasca ,Loukia Yiangou ,Hikari Osaki ,Faisal Basheer ,Paolo Gallipoli ,Natalie Burrows ,Ayşegül Erdem ,Anastasiya Sybirna ,Sarah Foerster ,Wanfeng Zhao ,Tonci Sustic ,Anna Petrunkina Harrison ,Elisa Laurenti ,Jessica Okosun ,Daniel Hodson ,Penny Wright ,Ken G Smith ,Patrick Maxwell ,Jude Fitzgibbon ,Ming Q Du ,David J Adams ,Brian J P Huntly

Abstract

Loss-of-function mutations of cyclic-AMP response element binding protein, binding protein (CREBBP) are prevalent in lymphoid malignancies. However, the tumour suppressor functions of CREBBP remain unclear. We demonstrate that loss of Crebbp in murine haematopoietic stem and progenitor cells (HSPCs) leads to increased development of B-cell lymphomas. This is preceded by accumulation of hyperproliferative lymphoid progenitors with a defective DNA damage response (DDR) due to a failure to acetylate p53. We identify a premalignant lymphoma stem cell population with decreased H3K27ac, which undergoes transcriptional and genetic evolution due to the altered DDR, resulting in lymphomagenesis. Importantly, when Crebbp is lost later in lymphopoiesis, cellular abnormalities are lost and tumour generation is attenuated. We also document that CREBBP mutations may occur in HSPCs from patients with CREBBP-mutated lymphoma. These data suggest that earlier loss of Crebbp is advantageous for lymphoid transformation and inform the cellular origins and subsequent evolution of lymphoid malignancies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。